Purpose of Review: This review highlights the expression and regulation of mucin in CRS and discusses its clinical implications. Recent Findings: Chronic rhinosinusitis (CRS) is common chronic nasal disease; one of its main manifestations and important features is mucus overproduction. Mucin is the major component of mucus and plays a critical role in the pathophysiological changes in CRS. The phenotype of CRS affects the expression of various mucins, especially in nasal polyps (NP). Corticosteroids(CS), human neutrophil elastase (HNE), and transforming growth factor-β1 (TGF-β1) are closely related to the tissue remodeling of CRS and regulate mucin expression, mainly MUC1, MUC4, MUC5AC, and MUC5B. “It is expected that CS, HNE and TGF - β could be used to regulate the expression of mucin in CRS.” However, at present, the research on mucin is mainly focused on mucin 5AC and mucin 5B, which is bad for finding new therapeutic targets. Summary: Investigating the expression and location of mucin in nasal mucosa and understanding the role of various inflammatory factors in mucin expression are helpful to figure out regulatory mechanisms of airway mucin hypersecretion. It is of great significance for the treatment of CRS.
CITATION STYLE
Tong, J., & Gu, Q. (2020, November 1). Expression and Clinical Significance of Mucin Gene in Chronic Rhinosinusitis. Current Allergy and Asthma Reports. Springer. https://doi.org/10.1007/s11882-020-00958-w
Mendeley helps you to discover research relevant for your work.